The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma
Abstract
There appear to be two pathways involved in the pathogenesis of premalignant non-immunoglobulin M (IgM) monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Nearly half of tumors are nonhyperdiploid, and mostly have one of five recurrent IgH translocations: 16% 11q13 (CCN D1), 3% 6p21 (CCN D3), 5% 16q23 (MAF), 2% 20q12 (MAFB), and 15% 4p16 (FGFR3 and MMSET). The remaining hyperdiploid tumors have multiple trisomies involving chromosomes 3, 5, 7, 9, 11, 15, 19, and 21, and infrequently one of these five translocations. Although cyclin D1 is not expressed by healthy lymphoid cells, it is bi-allelically dysregulated in a majority of hyperdiploid tumors. Virtually all MM and MGUS tumors have dysregulated and/or increased expression of cyclin D1, D2, or D3, providing an apparent early, unifying event in pathogenesis. The patterns of translocations and cyclin D expression (TC) define a novel classification that includes eight groups: 11q; 6p; MAF; 4p; D1 (34%); D1+D2 (6%); D2 (17%); and none (2%). The hyperdiploid D1 group is virtually absent in extramedullary MM and MM cell lines, suggesting a particularly strong dependence on interaction with the bone marrow microenvironment. Despite shared progression events (RAS mutations, MYC dysregulation, p53 mutations, and additional disruption of the retinoblastoma pathway), the phenotypes of MGUS and MM tumors in the eight TC groups is determined mainly by early oncogenic events. Similar to acute lymphocytic leukemia, MM seems to include several diseases (groups) that have differences in early or initiating events, global gene expression patterns, bone marrow dependence, clinical features, prognosis, and response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa01133202 · Cited by 1,475
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S. K., Küppers, R., & Dalla-Favera, R. (2001) · Nature · doi:10.1038/35085588 · Cited by 1,032
Multiple myeloma: evolving genetic events and host interactions
Kuehl, W. M., & Bergsagel, P. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc746 · Cited by 818
Self-citationCharacterization of clonogenic multiple myeloma cells
Matsui, W., Huff, C. A., Wang, Q., Malehorn, M. T., Barber, J., Tanhehco, Y., Smith, B. D., Civin, C. I., & Jones, R. J. (2004) · Blood · doi:10.1182/blood-2003-09-3064 · Cited by 789
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
Bergsagel, P. L., Kuehl, W. M., Zhan, F., Sawyer, J., Barlogie, B., & Shaughnessy, J. (2005) · Blood · doi:10.1182/blood-2005-01-0034 · Cited by 698
Self-citationClinical and biologic implications of recurrent genomic aberrations in myeloma
Fonseca, R., Blood, E., Rue, M., Harrington, D., Oken, M. M., Kyle, R. A., Dewald, G. W., Van Ness, B., Van Wier, S. A., Henderson, K. J., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3017 · Cited by 660
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Self-citationChesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Self-citationChromosome translocations in multiple myeloma
Bergsagel, P. L., & Kuehl, W. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204641 · Cited by 478
Self-citationChesi, M., Bergsagel, P. L., Shonukan, O. O., Martelli, M. L., Brents, L. A., Chen, T., Schröck, E., Ried, T., & Kuehl, W. M. (1998) · Blood · doi:10.1182/blood.v91.12.4457 · Cited by 401
Self-citationTricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D., Naucke, S., & Sawyer, Jr. (1995) · Blood · doi:10.1182/blood.v86.11.4250.bloodjournal86114250 · Cited by 395
Hypodiploidy is a major prognostic factor in multiple myeloma
Smadja, N. V., Bastard, C., Brigaudeau, C., Leroux, D., & Fruchart, C. (2001) · Blood · doi:10.1182/blood.v98.7.2229 · Cited by 390
Avet-Loiseau, H., Facon, T., Grosbois, B., Magrangeas, F., Rapp, M.-J., Harousseau, J.-L., Minvielle, S., & Bataille, R. (2002) · Blood · doi:10.1182/blood.v99.6.2185 · Cited by 358
Genomic abnormalities in monoclonal gammopathy of undetermined significance
Fonseca, R., Bailey, R. J., Ahmann, G. J., Rajkumar, S. V., Hoyer, J. D., Lust, J. A., Kyle, R. A., Gertz, M. A., Greipp, P. R., & Dewald, G. W. (2002) · Blood · doi:10.1182/blood.v100.4.1417.h81602001417_1417_1424 · Cited by 348
Shou, Y., Martelli, M. L., Gabrea, A., Qi, Y., Brents, L. A., Roschke, A., Dewald, G., Kirsch, I. R., Bergsagel, P. L., & Kuehl, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.228 · Cited by 347
Self-citationMyeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
Fonseca, R., Blood, E. A., Oken, M. M., Kyle, R. A., Dewald, G. W., Bailey, R. J., Van Wier, S. A., Henderson, K. J., Hoyer, J. D., Harrington, D., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3735 · Cited by 340
Moreau, P., Facon, T., Leleu, X., Morineau, N., Huyghe, P., Harousseau, J.-L., Bataille, R., & Avet-Loiseau, H. (2002) · Blood · doi:10.1182/blood-2002-03-0749 · Cited by 317
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
Fonseca, R., Debes-Marun, C. S., Picken, E. B., Dewald, G. W., Bryant, S. C., Winkler, J. M., Blood, E., Oken, M. M., Santana-Dávila, R., González-Paz, N., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0493 · Cited by 296
Chesi, M., Brents, L. A., Ely, S. A., Bais, C., Robbiani, D. F., Mesri, E. A., Kuehl, W. M., & Bergsagel, P. L. (2001) · Blood · doi:10.1182/blood.v97.3.729 · Cited by 289
Self-citationRearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
Avet-Loiseau, H., Gerson, F., Magrangeas, F., Minvielle, S., Harousseau, J.-L., & Bataille, R. (2001) · Blood · doi:10.1182/blood.v98.10.3082 · Cited by 289
Chesi, M., Bergsagel, P., Brents, L., Smith, C., Gerhard, D., & Kuehl, W. (1996) · Blood · doi:10.1182/blood.v88.2.674.bloodjournal882674 · Cited by 277
Self-citationShaughnessy, J., Gabrea, A., Qi, Y., Brents, L., Zhan, F., Tian, E., Sawyer, J., Barlogie, B., Bergsagel, P. L., & Kuehl, M. (2001) · Blood · doi:10.1182/blood.v98.1.217 · Cited by 223
Self-citationAvet-Loiseau, H., Garand, R., Lodé, L., Harousseau, J.-L., & Bataille, R. (2003) · Blood · doi:10.1182/blood-2002-08-2436 · Cited by 185
Cohen, H. J., Crawford, J., Rao, M. K., Pieper, C. F., & Currie, M. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00080-1 · Cited by 162
Fonseca, R., Oken, M., Harrington, D. P., Bailey, R., Wier, S. V., Henderson, K. J., Kay, N. E., Ness, B. V., Greipp, P., & Dewald, G. (2001) · Leukemia · doi:10.1038/sj.leu.2402125 · Cited by 140
Hayman, S. R., Bailey, R. J., Jalal, S. M., Ahmann, G. J., Dispenzieri, A. A., Gertz, M. A., Greipp, P. R., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., et al. (2001) · Blood · doi:10.1182/blood.v98.7.2266 · Cited by 140
Pilarski, L. M., Hipperson, G., Seeberger, K. L., et al. (2000) · Blood · doi:10.1182/blood.v95.3.1056.003k26_1056_1065 · Cited by 138
Familial Multiple Myeloma: a Family Study and Review of the Literature
Lynch, H. T., Sanger, W. G., Pirruccello, S. J., Quinn‐Laquer, B., & Weisenburger, D. D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.19.1479 · Cited by 103
Rajkumar, S. V., Fonseca, R., Dewald, G. W., et al. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00009-6 · Cited by 101
Smadja, N., Leroux, D., Soulier, J., Dumont, S., Arnould, C., Taviaux, S. A., Taillemite, J. L., & Bastard, C. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10275 · Cited by 97
Phenotypic Heterogeneity in Multiple Myeloma Families
Lynch, H. T., Watson, P. A., Tarantolo, S., Wiernik, P. H., Quinn‐Laquer, B., Bergsagel, K. I., Huiart, L., Olopade, O. I., Sobol, H., Sanger, W. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.126 · Cited by 63
Cited by
Palumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,433
Self-citationCyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,177
Metadata
- Authors
- Bergsagel, P. L., & Kuehl, W. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-09-10
- Volume
- 23
- Issue
- 26
- Pages
- 6333-6338
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1995246165
- Cited by
- 556
- References
- 31
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.